H-Index
79
Scimago Lab
powered by Scopus
JCR
Clarivate
Analytics
15%
Acceptance
Rate
call: +1.631.470.9640
Mon-Fri 10 am - 2 pm EST

Logo

Medical Science Monitor Basic Research
AmJCaseRep

Annals
ISI-Home

eISSN: 1643-3750

[Retracted]  Total intravenous anesthesia with propofol and remifentanil is associated with a nearly twofold higher incidence in postanesthetic shivering than desflurane-fentanyl anesthesia

Kerstin D Röhm, Jörn Riechmann, Joachim Boldt, Stefan W. Suttner, Swen N. Piper

Med Sci Monit 2006; 12(11): CR452-546

ID: 462571

Available online: 2006-11-01

Published: 2006-11-01


Background: Postanesthetic shivering (PAS) is a frequent side effect of general anesthesia. Previous reports on the incidence of PAS of propofol for the induction or maintenance of anesthesia have been controversial, but have not been studied in detail. The aim of the present study was to evaluate the incidence and severity of PAS in total intravenous anesthesia (TIVA) with propofol and remifentanil
compared with an inhalative anesthesia.
Material/Methods: After ethics committee approval and written informed consent from the patients, 53 patients scheduled for urologic, gynecologic, or surgical operations were studied for shivering postoperatively using a fi ve-point rating scale. They received desfl urane-fentanyl based anesthesia (n=27) or TIVA with propofol and remifentanil (n=26). Hemodynamics and temperature were measured after
induction of anesthesia (T0), and 5 min (T1), 15 min (T2), 30 min (T3), and 60 min (T4) after reaching the postanesthetic care unit (PACU).
Results: In the TIVA group, 18/26 (69.2%) patients suffered from PAS compared with 10/27 (37%) in the
desfl urane-fentanyl group (P

Keywords: Anesthesia, Intravenous, Anesthesia Recovery Period, Anesthetics, Intravenous - administration & dosage, Fentanyl - administration & dosage, Isoflurane - analogs & derivatives, Piperidines - administration & dosage, Propofol - administration & dosage, Shivering, Temperature, Time Factors




Back